SalutarisMD to Introduce its New Generation Medical Device for wet AMD Therapy at Ophthalmology Futures European Forum
COPENHAGEN, Denmark--(BUSINESS WIRE)--Today, Salutaris Medical Devices, Inc. (SalutarisMD®) announced that during its upcoming presentation at the Ophthalmology Futures European Forum on September 8, the Company will introduce its new generation, commercial ready, episcleral brachytherapy applicator system. The presentation by Dr. Laurence Marsteller, CEO, will discuss how the new SalutarisMD system (SMD-DA™) is designed to deliver improved dosimetry to wet AMD lesions and improved ease of use
